跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Broxan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Broxan
Approved
STANDARD
Broxan
Swiss Pharma Research Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
2c0b826b497e6625
Company
Swiss Pharma Research Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
2c0b826b497e6625
Drug Approval Philippines Name
Broxan
Product Name
Broxan
Registration Number
DR-XY26898
Brand Name
Broxan
Generic Name
Ambroxol Hydrochloride
Dosage Form
Syrup
Dosage Strength
15 mg/5 mL
Manufacturer
Swiss Pharma Research Laboratories, Inc.
Trader
Pharma Dynamic, Inc.
Issuance Date
25 March 2021
Expiry Date
12 March 2026
Pharmacologic Category
Mucolytic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
2c0b826b497e6625
Type
Standard
Back to Philippines FDA Approvals